Survival Times of Breast Cancer Patients in Nigeria
Published: 2023-09-21
Page: 209-223
Issue: 2023 - Volume 6 [Issue 1]
Samuel Babajide Atoyebi *
Department of Research and Data Analysis, DSK Statistical Consult Ltd., Nigeria.
Phillip Oluwatobi Awodutire
Department of Quantitative Health Sciences, Cleveland Clinic, USA.
Margaret Moyinoluwa Igbalajobi
Department of Health Care Research, University of Bristol, England.
Oluwadamilare Olukayode Anifowose
Department of Public Health, Macquarie University, Australia.
*Author to whom correspondence should be addressed.
Abstract
This paper presents comprehensive research into the survival times of breast cancer patients in Nigeria. Breast cancer is a significant global public health concern, and its impact is particularly profound in Nigeria due to unique socio-economic, cultural, and healthcare access factors. The immune system plays a crucial role in recognising and eliminating abnormal cells, including cancer cells. This study synthesises data from sixteen studies to provide a more robust estimation of survival times, enhance generalizability, and identify potential sources of heterogeneity among different cohorts. A comprehensive literature search of articles published about the survival rate of breast cancer in Nigeria was conducted using a snowballing approach in major electronic databases. Sixteen (16) publications were found to meet the inclusion criteria and were selected for the meta-analyses. R was used to perform all the analyses. The survival rate decreases as the time interval increases. The results showed that the survival rates for breast cancer in Nigeria were 68.8% at one year, 50% at three years, 33.3% at five years, and 11.1% at ten years. The study’s findings underscore both the challenges and progress in breast cancer mortality in the Nigerian context. Cancer makes people anxious, and anxiety affects value, so to improve survival rates and overall patient care, the Nigerian government should include mental health professionals in managing cancers. The findings of this study contribute to the global discourse on cancer management while also providing a tailored framework for improving outcomes within the unique Nigerian perspective.
Keywords: Breast cancer, survival times, Nigeria
How to Cite
Downloads
References
Sun YS, Zhao Z, Yang ZN, Xu F, Lu HJ, Zhu ZY, Shi W, Jiang J, Yao PP, Zhu HP, Risk factors and preventions of breast cancer. International journal of biological sciences. 2017;13(11):1387.
Atoyebi SB, Survival times of lung, breast, cervical, and prostate cancer patients in Africa. Journal of Cancer and Tumor International. 2023;13(1):9-28
DeSantis CE, Fedewa SA, Goding Sauer A, Kramer JL, Smith RA, Jemal A, Breast cancer statistics, 2015: Convergence of incidence rates between black and white women. CA: A Cancer journal for Clinicians. 2016;66(1):pp.31-42.
Watkins EJ, Overview of breast cancer. Journal of the American Academy of PAs, 2019;32(10):13-17.
Who.int. 2021. Cancer. Retrieved 9 June 2023, Available:https://www.who.int/news-room/fact-sheets/detail/cancer.
WHO. 2018. Latest world cancer sttistics, global cancer burden rises to 2.1 million new cases in 2018: Marked increase in breast cancer must be addressed. [hppt://globocan.iarc.fr]. GLOBOCAN 2018, International Cancer Research Institute of the World Health Organization. Lyon.
WHO. 2013b. Latest world cancer sttistics, global cancer burden rises to 14.1 million new cases in 2012: Marked increase in breast cancer must be addressed. [hppt://globocan.iarc.fr]. GLOBOCAN 2012, International cancer research institute of the World Health Organization. Lyon.
Siegel RL, Miller KD, Jemal A,. Cancer statistics, 2018. CA: A Cancer Journal for Clinicians. 2018;68(1):7-30.
Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F. Global cancer observatory: cancer today. International Agency for Research on Cancer. Lyon, France; 2020.
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Bray F.. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. International Journal of Cancer. 2015;136(5):359-386.
Atoyebi SB, Olayiwola MF, Oladapo JO, Oladapo DI. Forecasting Currency in Circulation in Nigeria Using Holt-Winters Exponential Smoothing Method. South Asian Journal of Social Studies and Economics. 2023;20(1):25-41.
Ntekim A, Nufu FT, Campbell OB, Breast cancer in young women in Ibadan, Nigeria. African Health Sciences. 2009;9(4).
Jedy-Agba E, Curado MP, Ogunbiyi O, Oga E, Fabowale T, Igbinoba F, Osubor G, Otu T, Kumai H, Koechlin A, Osinubi P. Cancer incidence in Nigeria: A report from population-based cancer registries. Cancer epidemiology. 2012;36(5):e271-e278.
Parkin DM, Ferlay J, Hamdi-Cherif M, Sitas F, Thomas JO, Wabinga H, Whelan SL. Cancer in Africa. Epidemiology and Prevention. 2003;4:268-276.
Campbell O, Agwimah R, Oduola B, Alawale E, Radiotherapy management of breast cancer in 400 Nigerians. Niger Med J. 1998;16:48.
Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Nikšić M, Bonaventure A, Valkov M, Johnson CJ, Estève J, Ogunbiyi OJ,. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): Analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. The Lancet. 2018;39(10125): 1023-1075.
Vorobiof DA, Sitas F, Vorobiof G, Breast cancer incidence in South Africa. Journal of clinical oncology, 19(18; SUPP), 2001;125s-125s.
Popoola AO, Ogunleye OO, Ibrahim NA, Omodele FO, Igwilo AI,. Five year survival of patients with breast cancer at the Lagos State University Teaching Hospital, Nigeria. J Med Med Sci Res. 2012;1:24-31.
Alabi OO, Saula AY, Gayawan E, Alabi VS, Bello HA, Akinbo RY, Lasisi TA. Survival Rate Analysis on Breast Cancer Cases at Univesity College Hospital, Ibadan, Nigeria. Open Journal of Statistics. 2022;12:238-260.
Ali-Gombe M, Mustapha MI, Folasire A, Ntekim A, Campbell OB. Pattern of survival of breast cancer patients in a tertiary hospital in South West Nigeria. Ecancermedicalscience. 2021;15.
Atoyebi OM, Atoyebi SB,. Do technology–based approaches reduce mathematics anxiety? A Systematic literature. International Journal of Research and Innovation in Social Science (IJRISS). 2022;6(10):502-509.
Atoyebi SB, Atoyebi OM., The link between mathematics teaching strategies and students’ anxiety. Asian Journal of Education and Social Studies. 2022;33(4): 48-57.
National Institutes of Health. Study quality assessment tools. Natl Institutes Heal. 2018;1-35
Johns Hopkins Sheridan Libraries. Guides: evaluating information. 2018. Available:http://guides.library.jhu.edu/evaluate (accessed 24 April 2023)
Atoyebi OM, Atoyebi SB,. A Meta-analytic Review of the Relationship between Mathematics Anxiety and the Mathematical Thinking of Africa Students. Archives of Current Research International. 2022;22(7):15-28.
Nabegu AA, Muhammad MU, Abdullahi, N, Survival analysis of breast cancer patients in Kano state. FUDMA Journal of Sciences (FJS). 2023;7(2):199-205.
Akanno FC, Obasi CC, Chukwuocha UM, Dozie UW, Ori CLU, Sule GIO, Ijeoma-Ogu A. Innocent DC, Survival times of breast cancer patients in nigeria: application of cox and parametric survival models. African Journal of Biology and Medical Research. 2023;6(2):84-97.
Olayide A, Isiaka A, Ganiyu R, Samuel O, Halimat A, Olalekan O, Julius O, Anya R,. Breast Cancer Treatment and Outcomes in Nigeria: A Systematic Review and Meta-analysis. Asian Pacific Journal of Cancer Care. 2023;8(3):591-598.
Olaogun J, Agodirin O., Etonyeaku A, Idowu D.. Metastatic breast cancer in a tertiary hospital in South-Western Nigeria. Turkish Journal of Oncology. 2023;38(2): 162-169.
Alabi OO, Saula AY, Gayawan E, Alabi VS, Bello HA, Akinbo RY, Lasisi TA, Survival Rate Analysis on Breast Cancer Cases at Univesity College Hospital, Ibadan, Nigeria. Open Journal of Statistics. 2022;12:238-260.
Knapp GC, Tansley G, Olasehinde O, Wuraola F, Adisa A, Arowolo O, Olawole, M.O., Romanoff, A.M., Quan ML, Bouchard‐Fortier A, Alatise OI,. Geospatial access predicts cancer stage at presentation and outcomes for patients with breast cancer in southwest Nigeria: A population‐based study. Cancer. 2021;127(9):1432-1438.
Olasehinde O, Alatise O, Omisore A, Wuraola F, Odujoko O, Romanoff A, Akinkuolie A, Arowolo O, Adisa A, Knapp, G. and Famurewa O.. Contemporary management of breast cancer in Nigeria: Insights from an institutional database. International Journal of Cancer. 2021;148(12):2906-2914.
Olaogun JG, Omotayo JA, Ige JT, Omonisi AE, Akute OO, Aduayi OS, Socio-demographic, pattern of presentation and management outcome of breast cancer in a semi-urban tertiary health institution. Pan African Medical Journal. 2020;36(1).
Aliyu UM. Kehinde A, Tolerance and outcome of hypofractionated post-mastectomy radiotherapy among elderly breast cancer patients in a specialised center in Nigeria. Translational Cancer Research. 2020;9(11):6833.
Popoola OP, Oluwagbenga A, Popoola AT. Survival analysis of breast cancer in Nigeria. Annals. Computer Science Series. 2019;17(1).
Ayandipo OO, Adeleye AO, Ulasi IB Ogundiran TO, Outcome of cerebral metastasectomy in select cases of brain metastases from breast cancer in Ibadan, Nigeria. World Neurosurgery. 2019;127: 186-193.
Ntekim AI, Folasire AM, Ali-Gombe M. Survival pattern of rare histological types of breast cancer in a Nigerian institution. Pan African Medical Journal. 2019;34(1).
Awodutire P, Olapade A, Kolawole O, Ilori O, Assessing survival times of breast cancer patients using type I generalised half logistic survival model. Journal of Advances in Medicine and Medical Research. 2018;25(2):1-7.
Akinde OR, Phillips AA, Oguntunde OA. Afolayan OM, 2015. Cancer mortality pattern in Lagos university teaching hospital, Lagos, Nigeria. Journal Of Cancer Epidemiology; 2015..
Kene TS, Odigie VI, Yusufu LM, Yusuf BO, Shehu SM, Kase JT, Pattern of presentation and survival of breast cancer in a teaching hospital in north Western Nigeria. Oman Medical Journal. 2010;25(2):104.
Woods LM, Rachet B, O’Connell D, Lawrence, G., Tracey, E., Willmore, A. and Coleman MP, Large differences in patterns of breast cancer survival between Australia and England: A comparative study using cancer registry data. International Journal Of Cancer. 2009;124(10):2391-2399.
Fleming KA, Horton S, Wilson ML, Atun R, DeStigter K, Flanigan J, Sayed S, Adam P, Aguilar B, Andronikou S, Boehme C. The lancet commission on diagnostics: transforming access to diagnostics. The Lancet. 2021;398(10315):1997-2050.
Ingleby FC, Woods LM, Atherton IM, Baker M, Elliss-Brookes L. Belot A., An investigation of cancer survival inequalities associated with individual-level socio-economic status, area-level deprivation, and contextual effects, in a cancer patient cohort in England and Wales. BMC Public Health. 2022;22:1-12.
Niyonsenga G, Gishoma D, Sego R, Uwayezu MG, Nikuze B, Fitch M. Igiraneza PC, Knowledge, utilisation and barriers of cervical cancer screening among women attending selected district hospitals in Kigali-Rwanda. Canadian Oncology Nursing Journal. 2021;31(3):266.
Ssentongo P, Lewcun JA, Candela X, Ssentongo AE, Kwon EG, Ba DM, Oh JS, Amponsah-Manu F, McDonald AC, Chinchilli VM, Soybel DI, Regional, racial, gender, and tumor biology disparities in breast cancer survival rates in Africa: a systematic review and meta-analysis. PloS One. 2019;14(11):e0225039.
Moodley J, Constant D, Mwaka AD, Scott SE, Walter FM. Anticipated help seeking behaviour and barriers to seeking care for possible breast and cervical cancer symptoms in Uganda and South Africa. Ecancermedicalscience. 2021;15.
Zhu J, Chen JG, Chen YS, Zhang YH, Ding LL, Chen TY, Female breast cancer survival in Qidong, China. 1972–2011: A population-based study. BMC Cancer. 2014;4(1):1-7.
Yeole BB, Kumar AVR, Kurkure A. Sunny L., Population-based survival from cancers of breast, cervix and ovary in women in Mumbai, India. Asian Pacific Journal of Cancer Prevention. 2004;5(3):308-315.
Sankaranarayanan R, Swaminathan R, Brenner H, Chen K, Chia KS, Chen JG, Law SC, Ahn YO, Xiang YB, Yeole BB. Shin HR.,. Cancer survival in Africa, Asia, and Central America: a population-based study. The Lancet Oncology. 2010;11(2), 165-173.
Alabi OO, Saula AY, Gayawan E, Alabi VS. Bello HA, Akinbo RY, Lasisi TA.. Survival Rate Analysis on Breast Cancer Cases at Univesity College Hospital, Ibadan, Nigeria. Open Journal of Statistics. 2022;12:238-260.
Omar S, Alieldin NHM, Khatib OMN,. Cancer magnitude, challenges and control in the Eastern Mediterranean Region. EMHJ-Eastern Mediterranean Health Journal. 2007;13(6):1486-1496.
Khatib O, Aljurf M,. Cancer prevention and control in the Eastern Mediterranean region: the need for a public health approach. Hematology/oncology and Stem Cell Therapy. 2008;1(1):44-52.
Allemani C, Sant M, Weir HK., Richardson, LC, Baili P, Storm H, Siesling S, Torrella‐Ramos A, Voogd AC, Aareleid T. and Ardanaz E,. Breast cancer survival in the US and Europe: A CONCORD high‐resolution study. International Journal of Cancer. 2013;132(5):1170-1181.
Kachuri L, De P, Ellison LF, Semenciw R,. Cancer incidence, mortality and survival trends in Canada, 1970-2007. Chronic Diseases and Injuries in Canada. 2013; 33(2).